← Scroll for more →
Financial Statements — PHAR
Balance Sheet
(in millions USD)| Metric | Q4 2025 | Q4 2024 | Q4 2023 | Q4 2022 | Q4 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 145.31 | 54.94 | 61.74 | 207.34 | 191.92 |
| Inventory | 64.90 | 55.72 | 56.76 | 42.33 | 27.31 |
| Total Current Assets | 299.47 | 278.44 | 316.34 | 277.50 | 249.44 |
| Total Non-current Assets | 200.50 | 121.55 | 146.51 | 148.30 | 147.87 |
| Total Assets | 499.96 | 399.99 | 462.85 | 425.80 | 397.32 |
| Total Current Liabilities | 115.79 | 73.80 | 77.97 | 59.70 | 46.77 |
| Total Non-current Liabilities | 107.07 | 105.12 | 166.11 | 161.46 | 157.63 |
| Total Liabilities* | 222.86 | 178.92 | 244.07 | 221.16 | 204.40 |
| Retained Earnings | (272.98) | (275.49) | (265.26) | (256.43) | (273.17) |
| Total Stockholder Equity | 277.10 | 221.06 | 218.78 | 204.64 | 192.92 |
← Scroll for more columns →
* Derived from reported values